If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/Letter to the editor
2020

The authors reply

van Bommel, E. J. M. & van Raalte, D. H., Apr 2020, In : Kidney International. 97, 4, p. 806 1 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

SGLT2 inhibitors’ interaction with other renoactive drugs in type 2 diabetes patients: still a lot to learn

van Baar, M. J. B., Scholtes, R. A. & van Raalte, D. H., 2019, In : Kidney International. 96, 2, p. 283-286

Research output: Contribution to journalComment/Letter to the editorAcademic

2018

Canagliflozine, een nieuw glucoseverlagend middel

Translated title of the contribution: Canagliflozin, a new glucose-lowering agent: Effect on heart failure in patients with type 2 diabetes mellitusVan Raalte, D. H. & Van Baar, M., 1 Jan 2018, In : Nederlands Tijdschrift voor Geneeskunde. 162, 18, D2755.

Research output: Contribution to journalComment/Letter to the editorProfessional

Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography

Deschasaux, M. L., Bouter, K. E., Prodan, A., Levin, E., Groen, A. K., Herrema, H., Tremaroli, V., Bakker, G. J., Attaye, I., Pinto-Sietsma, S-J., van Raalte, D. H., Snijder, M. B., Nicolaou, M., Peters, R., Zwinderman, A. H., Bäckhed, F. & Nieuwdorp, M., 2018, In : Nature Medicine. 24, 10, p. 1526-1531

Research output: Contribution to journalComment/Letter to the editorAcademic

GLP-1 receptor agonists, CKD, and eGFR trajectory

van Baar, M. J. B., van Raalte, D. H. & Muskiet, M. H. A., 2018, In : Lancet diabetes & endocrinology. 6, 10, p. 764-765 2 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Renal outcomes in CVOTs: keep calm and carry on

Muskiet, M. H. A., van Baar, M. J. B., Scholtes, R. A. & van Raalte, D. H., 1 Sep 2018, In : The Lancet Diabetes and Endocrinology. 6, 9, p. 674-676 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Sodium glucose cotransporter 2 inhibition and renal ischemia: implications for future clinical trials

van Raalte, D. H. & Cherney, D. Z. I., 2018, In : Kidney International. 94, 3, p. 459-462

Research output: Contribution to journalComment/Letter to the editorAcademic

2017

SGLT2 inhibition: a new era in renoprotective medicine?

Muskiet, M. H. A., Heerspink, H. J. L. & van Raalte, D. H., 1 Aug 2017, In : The Lancet Diabetes and Endocrinology. 5, 8, p. 569-571 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

2016

Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes

Muskiet, M. H. A., van Bommel, E. J. M. & van Raalte, D. H., Mar 2016, In : Lancet diabetes & endocrinology. 4, 3, p. 188-189

Research output: Contribution to journalComment/Letter to the editorAcademic